| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Singleton J Matthew is a Director at Viking Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 11 sells.
Estimated insider holdings value: $409K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 25, 2024 | VKTX Viking Therapeutics, Inc. | Director | Sale+OE | 16,000 | $79.50 | $1,272,000.00 | -62.7% | -55.2% | -55.9% | |
| Sep 20, 2024 | VKTX Viking Therapeutics, Inc. | Director | Sale+OE | 10,300 | $69.50 | $715,850.00 | -52.0% | -41.1% | -64.0% | |
| Aug 21, 2024 | VKTX Viking Therapeutics, Inc. | Director | Sale+OE | 5,700 | $69.72 | $397,430.22 | -37.5% | -20.5% | -60.4% | |
| Aug 19, 2024 | VKTX Viking Therapeutics, Inc. | Director | Sale+OE | 16,000 | $62.22 | $995,453.24 | -14.8% | -26.3% | -63.4% | |
| Aug 14, 2024 | VKTX Viking Therapeutics, Inc. | Director | Sale+OE | 20,786 | $57.53 | $1,195,736.21 | -52.0% | +4.1% | -30.9% | |
| May 31, 2018 | VKTX Viking Therapeutics, Inc. | Director | Buy | 9,500 | $9.82 | $93,260.55 | New | - | - |